Core Laboratories (NYSE:CLB) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Core Laboratories (NYSE:CLB - Get Free Report) announced its quarterly earnings data on Wednesday. The oil and gas company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.18 by $0.01, Zacks reports. Core Laboratories had a net margin of 5.73% and a return on equity of 14.28%. The firm had revenue of $130.16 million for the quarter, compared to the consensus estimate of $129.19 million. During the same period last year, the firm earned $0.22 EPS. The company's revenue was down .3% on a year-over-year basis. Core Laboratories updated its Q3 2025 guidance to 0.180-0.220 EPS.

Core Laboratories Trading Down 12.2%

Core Laboratories stock traded down $1.63 during trading on Friday, hitting $11.73. The company's stock had a trading volume of 815,069 shares, compared to its average volume of 455,720. The stock's fifty day moving average is $11.83 and its 200 day moving average is $13.90. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.64 and a current ratio of 2.21. Core Laboratories has a 1-year low of $10.14 and a 1-year high of $25.13. The stock has a market capitalization of $549.71 million, a price-to-earnings ratio of 18.91, a P/E/G ratio of 3.88 and a beta of 1.41.

Core Laboratories Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 25th. Investors of record on Monday, August 4th will be given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.34%. The ex-dividend date is Monday, August 4th. Core Laboratories's dividend payout ratio is presently 6.78%.

Institutional Trading of Core Laboratories

An institutional investor recently raised its position in Core Laboratories stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 4.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,893 shares of the oil and gas company's stock after buying an additional 1,170 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned about 0.06% of Core Laboratories worth $418,000 at the end of the most recent reporting period. 97.81% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have commented on the stock. Stifel Nicolaus dropped their target price on shares of Core Laboratories from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Wednesday, July 16th. Wall Street Zen lowered shares of Core Laboratories from a "hold" rating to a "sell" rating in a research note on Friday, April 25th. Finally, Citigroup reduced their price objective on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 13th.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.